Mayo Clinic Minute: What is chimeric antigen receptor-T cell therapy?

Roughly 620,000 new cases of lymphoma were diagnosed worldwide, according to the World Cancer Research Fund International’s 2020 report. Survival rates have improved as advances develop in treatment, such as chimeric antigen receptor-T cell therapy (CAR-T cell therapy). Watch: The Mayo Clinic Minute Journalists: Broadcast-quality video (1:02) is available in the downloads at the end of the post. Please courtesy: “Mayo Clinic News Network.” Read the script. CAR-T cell therapy is a personalized treatment giving hope to…

Recommend0 recommendationsPublished in national-health-sources